Dossier
Bristol Myers
Coverage of Bristol Myers in the Nexus archive.
- How AstraZeneca’s $400bn tie-up with US rival Bristol Myers unravelled
The article details how a potential $400bn tie-up and merger between AstraZeneca and its US rival, Bristol Myers, ultimately unravelled. Had this mega-deal proceeded, it would have represented a notable return to major pharma megadeals.
- Jim Cramer's top 10 things to watch in the stock market Monday
Semiconductor stocks are rising, and Bristol Myers is purchasing new Nvidia chips for AI-driven drug discovery.